Skip to main content
About the Institute
  • English

Breadcrumb

  1. Home
  2. Microbiota 24 - March 2026
  3. PFAS and microbiota
  • Our publications
    • News
    • HCP Magazine
    • Thematic pages
    • Thematic folders
    • Overviews - Microbiota Magazine
  • About the Institute
    • About us
    • International Microbiota Observatory
    • Press room
    • Partnerships
  • Congresses
    • Congress calendar
    • Congress reviews
  • Continuing Medical Education
    • Accrediting courses
  • Useful documents
    • How to talk about
    • Infographics
    • Diagnosis tools
    • Patients Stories
    • Experts' point of view

    Join the microbiota community

    • Facebook
    • Twitter
    • LinkedIn
    • YouTube
    • Instagram
    • Bluesky

Lay public section

Find here your dedicated section
Gastroenterology
Gynecology
Pediatrics
General Medicine

Breadcrumb

  1. Home
  2. Microbiota 24 - March 2026
  3. PFAS and microbiota

PFAS and microbiota

By Anaïs Bodon, Muriel Mercier-Bonin, Bruno Sovran
Neuro-Gastroenterology and Nutrition Team at INRAE (National Research Institute for Agriculture, Food and Environment), Toxalim, Toulouse, France

Gastroenterology
Gynecology
Pediatrics
General Medicine
  • Our publications
    • News
    • HCP Magazine
    • Thematic pages
    • Thematic folders
    • Overviews - Microbiota Magazine
  • About the Institute
    • About us
    • International Microbiota Observatory
    • Press room
    • Partnerships
  • Congresses
    • Congress calendar
    • Congress reviews
  • Continuing Medical Education
    • Accrediting courses
  • Useful documents
    • How to talk about
    • Infographics
    • Diagnosis tools
    • Patients Stories
    • Experts' point of view

    Join the microbiota community

    • Facebook
    • Twitter
    • LinkedIn
    • YouTube
    • Instagram
    • Bluesky

Lay public section

Find here your dedicated section

Sources

This article is based on scientific information

Sharing is caring

Your colleagues might be interested in this topic. Why not share it?

  • Facebook
  • Twitter
  • LinkedIn
  • Mail

Sections

About this article

Created 21 April 2026
Updated 24 April 2026

Per- and polyfluoroalkyl substances (PFAS) are a large family of chemical compounds commonly referred to as “forever chemicals” due to their extreme persistence in the environment and ecosystems. Their fire-retardant, water-repellent, and heat-resistant properties have led to their widespread use in many everyday products (nonstick cookware, waterproof textiles, etc.). PFAS are highly resistant to degradation, accumulate in the environment, contaminate the food chain, and lead to widespread human exposure. PFAS thus accumulate in the body with documented health effects, albeit for a limited number of compounds.

Are the claims made on social media justified?

In the laboratory, under very specific experimental conditions, certain bacteria in the gut microbiota 1 or lactic acid bacteria 2 (often used as probiotics) can bioaccumulate PFAS or “sequester” them on their surface, suggesting a possible “detoxification effect.” In practice, however, ingested PFAS are almost entirely absorbed in the small intestine and rapidly enter the bloodstream. The gut microbiota is mainly located in the colon, a compartment that is only minimally exposed to PFAS, although a small fraction of the microbiota, located in the small intestine, is directly exposed. As a result, direct contact between PFAS and intestinal bacteria remains marginal compared with the total amount of PFAS already accumulated in the body. Based on current knowledge, it is therefore difficult to conclude that the microbiota and/or probiotic intake play a major role, contrary to what is suggested in the media, in the microbial detoxification of total PFAS from the body.

What are the impacts on the microbiota?

Furthermore, this limited contact may nevertheless contribute to the increasingly documented effects of PFAS on the gut microbiota. Studies in rodents show that PFAS exposure can alter the composition of the microbiota and disrupt some of its functions, including metabolites production and interactions with the immune system 3,4. These alterations have been shown to disrupt the balance of the digestive ecosystem and impair intestinal health.

Are there any important limitations to keep in mind?

Most of the available scientific data comes from animal models exposed to doses generally higher than those representative of human exposure, and concerns a very limited number of PFAS, often studied individually. In humans, studies remain rare, mainly observational, and influenced by many confounding factors (e.g. diet, age, sex). Research on PFAS-microbiota interactions is therefore still emerging.

What are the implications for healthcare professionals and how should they respond to patients?

Given the media coverage of the topic and patients’ concerns, it is essential to communicate on the basis of scientific evidence, without excessive extrapolation. It should be explained that there is no “miracle” solution for PFAS detoxification, particularly through probiotics.

In practice, healthcare professionals can advise limiting known sources of PFAS exposure (e.g. food packaging, non-stick cookware) and encouraging a varied, minimally processed diet rich in fruits, vegetables, and whole grains to support the protective function of the microbiota.

Sources

1. Lindell AE, Grießhammer A, Michaelis L, et al. Human gut bacteria bioaccumulate per-and polyfluoroalkyl substances. Nat Microbiol 2025 ; 10 : 1630-47.

2. Xing J, Wang F, Xu Q, et al. Screening of potential probiotic lactic acid bacteria based on gastrointestinal properties and perfluorooctanoate toxicity. Appl Microbiol Biotechnol 2016 ; 100 : 6755-66.

3. Zhang L, Rimal B, Nichols RG, et al. Perfluorooctane sulfonate alters gut microbiota- host metabolic homeostasis in mice. Toxicology 2020 ; 431 : 152365.

4. Shi L, Pan R, Lin G, et al. Lactic acid bacteria alleviate liver damage caused by perfluorooctanoic acid exposure via antioxidant capacity, biosorption capacity and gut microbiota regulation. Ecotoxicol Environ Saf 2021 ; 222 : 112515.

Tags
Microbiome Flora
    Focus
    Microbiota 24 - March 2026
    • Overview
      • Chronic pelvic pain and brain-gut axis: what is the involvement of the gut microbiota?
    • Commented articles
      • Pooled analysis of 3,741 faecal metagenomes from 18 cohorts for the identification of reproducible microbial biomarkers at different stages of colorectal cancer
      • Symptom-specific gut microbial and metabolic profiles in ADHD reveal SCFA deficiency as a key pathogenic mechanism
    • Congress review
      • Microbiota and Pediatric Health: Highlights from LASPGHAN 2025
    • Expert opinion
      • PFAS and microbiota
    • Press review
      • Gut microbiota #24
      • Vaginal microbiota #24
    Created 21 April 2026
    Updated 24 April 2026

    About this article

    To know more about this topic.

    Content type

    Expert opinion
    Microbiota and Pediatric Health: Highlights from LASPGHAN 2025
    Gut microbiota #24
    Focus

    Microbiota 24 - March 2026

    Overview

    Chronic pelvic pain and brain-gut axis: what is the involvement of the gut microbiota?

    Commented articles

    Pooled analysis of 3,741 faecal metagenomes from 18 cohorts for the identification of reproducible microbial biomarkers at different stages of colorectal cancer Symptom-specific gut microbial and metabolic profiles in ADHD reveal SCFA deficiency as a key pathogenic mechanism

    Congress review

    Microbiota and Pediatric Health: Highlights from LASPGHAN 2025

    Expert opinion

    PFAS and microbiota

    Press review

    Gut microbiota #24 Vaginal microbiota #24
    • Our publications
      • News
      • HCP Magazine
      • Thematic pages
      • Thematic folders
      • Overviews - Microbiota Magazine
    • About the Institute
      • About us
      • International Microbiota Observatory
      • Press room
      • Partnerships
    • Congresses
      • Congress calendar
      • Congress reviews
    • Continuing Medical Education
      • Accrediting courses
    • Useful documents
      • How to talk about
      • Infographics
      • Diagnosis tools
      • Patients Stories
      • Experts' point of view

      Join the microbiota community

      • Facebook
      • Twitter
      • LinkedIn
      • YouTube
      • Instagram
      • Bluesky

    Lay public section

    Find here your dedicated section
    Gastroenterology
    Gynecology
    Pediatrics
    General Medicine
    • English

    Browse the site

    • Our publications
      • News
      • HCP Magazine
      • Thematic pages
      • Thematic folders
      • Overviews - Microbiota Magazine
    • About the Institute
      • About us
      • International Microbiota Observatory
      • Press room
      • Partnerships
    • Congresses
      • Congress calendar
      • Congress reviews
    • Continuing Medical Education
      • Accrediting courses
    • Useful documents
      • How to talk about
      • Infographics
      • Diagnosis tools
      • Patients Stories
      • Experts' point of view

      Join the microbiota community

      • Facebook
      • Twitter
      • LinkedIn
      • YouTube
      • Instagram
      • Bluesky

    Lay public section

    Find here your dedicated section

    Discover

    Gastroenterology
    Gynecology
    Pediatrics
    General Medicine

    Join the microbiota community

    • Facebook
    • Twitter
    • LinkedIn
    • YouTube
    • Instagram
    • Bluesky

    Lay public section

    Find here your dedicated section

    Redirection

    You are about to be redirected and leave our website

    • Be redirected
    • Stay on the Biocodex Microbiota Institute's website

    Stay with us !

    Join the Microbiota Community of HCPs and researchers and receive “Microbiota Digest” and "HCP Magazine" to stay up to date on the latest news about microbiota.

    * Mandatory Fields

    BMI 20-35

    Explore

    Actu PRO : Un catalogue des gènes du microbiote vaginal
    21.04.2026

    Vaginal microbiota #24

    Read the article
    21.04.2026

    Gut microbiota #24

    Read the article
    21.04.2026

    PFAS and microbiota

    Read the article

    Stay updated

    Join the Microbiota Community of HCPs and researchers and receive “Microbiota Digest” and "HCP Magazine" to stay up to date on the latest news about microbiota.

    * Mandatory Fields

    BMI 20-35

    • Our publications
      • News
      • HCP Magazine
      • Thematic pages
      • Thematic folders
      • Overviews - Microbiota Magazine
    • About the Institute
      • About us
      • International Microbiota Observatory
      • Press room
      • Partnerships
    • Congresses
      • Congress calendar
      • Congress reviews
    • Continuing Medical Education
      • Accrediting courses
    • Useful documents
      • How to talk about
      • Infographics
      • Diagnosis tools
      • Patients Stories
      • Experts' point of view

      Join the microbiota community

      • Facebook
      • Twitter
      • LinkedIn
      • YouTube
      • Instagram
      • Bluesky

    Lay public section

    Find here your dedicated section

    Discover

    Gastroenterology
    Gynecology
    Pediatrics
    General Medicine

    Lay public section

    Find here your dedicated section

    Join the microbiota community

    • Facebook
    • Twitter
    • LinkedIn
    • YouTube
    • Instagram
    • Bluesky

    © 2026 Biocodex. All rights reserved.

    • Legal notice
    • GTU
    • Data protection policy
    • Sitemap
    • Cookies settings
    • Digital accessibility : partially compliant
    Biocodex logo